Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

2013 FDA drug approvals

This article has been updated

Although the FDA's 27 new approvals are down from the 15-year high of 2012, the newcomers pack powerful commercial potential.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1: FDA NME approvals since 1993.
Figure 2: Aggregate peak drug sales since 2004.
Figure 3

Change history

  • 07 February 2014

    The titles of David Greber and Ulrik Schulze have been updated online.

Authors

PowerPoint slides

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Mullard, A. 2013 FDA drug approvals. Nat Rev Drug Discov 13, 85–89 (2014). https://doi.org/10.1038/nrd4239

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd4239

This article is cited by

Search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research